New blood-based biomarker tests offer a less invasive and more accessible way to detect Alzheimer’s. But coverage gaps persist, particularly regarding Medicare’s ability to cover blood tests as screening tools. Working to close those gaps, strengthen the role of primary care in early detection, and ensure that these new tools reach the patients who need them most are critical to making progress against this costly chronic disease. pfcdalz.org/alzheimers

Cheaper Drugs, Higher Healthcare Costs? realclearhealth.com/articles…

PFCD remains committed to supporting continued research, thoughtful evaluation of evidence, and policies that accelerate progress for the millions of Americans affected by Alzheimer's disease. fightchronicdisease.org/post… #Fight4Health #EndAlz

For millions living with chronic conditions, pain isn’t occasional, it’s daily. And for too long, relief came with serious risks. New non-opioid therapies show patients shouldn’t have to choose between managing pain and protecting their future. That’s the kind of innovation patients deserve. inc.com/chase-feiger/the-opi… #Fight4Health

Advancing standards of care for the 7 million people navigating the challenges of #Alzheimers is critical to making America healthy and must remain a priority for Congress. #Fight4Health #EndAlz thehill.com/p/healthcare/575…

Although Congress has expressly prohibited the use of QALYs by certain federal programs to avoid discriminatory impacts, the "Most Favored Nation" executive order and the new Medicare/Medicaid models effectively import QALY-based valuations through international reference pricing. @KennethThorpe @joeymattingly healthaffairs.org/content/fo…

Great piece by @KennethThorpe on CMS, Drug Price negotiations and unintended consequences: 🧵 Medicare’s new drug-price “negotiation” list is meant to cut costs. Prof. Thorpe argues it could raise long-run spending if it slows the arrival of cheaper generics & biosimilars.

How would tying U.S. drug prices to those in foreign countries through a “Most Favored Nation” model impact Medicaid beneficiaries’ access to essential and lifesaving medications, especially for patients with chronic or rare conditions? Find out what @CaregiverAction's Marvell Adams thinks: youtube.com/watch?v=1VW_-G_C…

Congress must ensure that advancements in #alzheimers care benefit everyone, especially for communities with higher rates of Alzheimer's. The #asapact would help remove access barriers and bring innovative new screenings within reach. Thanks to @FSHCC president Julio Fuentes for sharing this message.

7.2M Americans live with #Alzheimers. The #ASAPAct lets Medicare cover blood-based screening to detect it years earlier. Grateful to @SenatorCollins, @CortezMasto, @MarkWarner, @SenCapito, @VernBuchanan @RepPaulTonko for championing this! fightchronicdisease.org/post… #Fight4Health #ENDALZ

Thank you @SenFinance for taking up the rising costs of health care and solutions that can better support the millions of American individuals and families navigating one and often multiple chronic conditions. #Fight4Health

We urge policymakers to reject foreign pricing models that will not meaningfully improve patient affordability or access. #Fight4Health fightchronicdisease.org/post…

Evolving public policy on #obesity is essential - acknowledge it as a serious public health concern that is incredibly costly, reduces workforce productivity, contributes to a host of comorbidities. Obesity is an epidemic, but comprehensive coverage works – and the potential benefits of a healthier America are too significant to ignore. #Fight4Health

While the administration focuses on prevention, it must not forget those patients who are sick. Before I developed multiple sclerosis more than 30 years ago, I had no family history of disease, had lived a healthy lifestyle, and yet I was still struck by this chronic illness…we must also embrace the development of innovative treatments and cures to combat the diseases afflicting patients. dcjournal.com/maha-shouldnt-… #Fight4Health

PFCD’s @KennethThorpe will be presenting at the @PHAVoice Innovation and Adoption Summit today on The Future of Chronic Care - Policy Implications. Learn more and register here: lnkd.in/dwGmw-_Z

.@KennethThorpe will be presenting @PHAVoiceat Innovation and Adoption Summit about "The Future of Chronic Care - Policy Implications." Join us! Top of the Hill Conference Center, Washington, D.C.  September 29–30, 2025 - Register here:  phainnovationsummit.com/

Even Modest Weight Loss Tied to Lower Health Care Spending healthday.com/healthpro-news… #

"We must address #obesity as the disease it is... Reducing obesity lowers costs across several chronic conditions and should be a priority focus for employers, @MedicareGov and other payors moving forward" @KennethThorpe #Fight4Health fightchronicdisease.org/obes…

A recent study reveals if every American living with obesity hypothetically reduced their body mass index (BMI) by 5%, the cumulative effect would save $68.1 billion in annual private health insurance spending and $21.7 billion in #Medicare. BLOG: fightchronicdisease.org/blog…